Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation.
Taura K, Shimamura T, Akamatsu N, Umeshita K, Fujiyoshi M, Abe H, Morita S, Uemoto S, Eguchi S, Furukawa H, Takada Y, Egawa H, Ohdan H, Hatano E; Japanese Liver Transplantation Society. Taura K, et al. Among authors: morita s. J Hepatobiliary Pancreat Sci. 2022 May;29(5):570-584. doi: 10.1002/jhbp.1134. Epub 2022 Mar 22. J Hepatobiliary Pancreat Sci. 2022. PMID: 35279950
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).
Shimada M, Morine Y, Nagano H, Hatano E, Kaiho T, Miyazaki M, Kono T, Kamiyama T, Morita S, Sakamoto J, Kusano M, Saji S, Kanematsu T, Kitajima M. Shimada M, et al. Among authors: morita s. Int J Clin Oncol. 2015 Feb;20(1):95-104. doi: 10.1007/s10147-014-0678-2. Epub 2014 Mar 6. Int J Clin Oncol. 2015. PMID: 24595550 Clinical Trial.
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.
Kobayashi S, Nagano H, Sakai D, Eguchi H, Hatano E, Kanai M, Seo S, Taura K, Fujiwara Y, Ajiki T, Takemura S, Kubo S, Yanagimoto H, Toyokawa H, Tsuji A, Terajima H, Morita S, Ioka T. Kobayashi S, et al. Among authors: morita s. Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709. doi: 10.1007/s00280-014-2543-4. Epub 2014 Jul 30. Cancer Chemother Pharmacol. 2014. PMID: 25074036 Clinical Trial.
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting.
Kondo M, Morimoto M, Ishii T, Nozaki A, Fukuda H, Numata K, Kobayashi S, Ohkawa S, Hidaka H, Nakazawa T, Shibuya A, Okuse C, Suzuki M, Sakamaki K, Morita S, Maeda S, Tanaka K. Kondo M, et al. Among authors: morita s. J Dig Dis. 2015 Mar;16(3):143-51. doi: 10.1111/1751-2980.12221. J Dig Dis. 2015. PMID: 25495751
Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T. Kou T, et al. Among authors: morita s. Int J Clin Oncol. 2016 Feb;21(1):118-25. doi: 10.1007/s10147-015-0864-x. Epub 2015 Jun 28. Int J Clin Oncol. 2016. PMID: 26123314
Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in Japan.
Sakamoto K, Honda G, Beppu T, Kotake K, Yamamoto M, Takahashi K, Endo I, Hasegawa K, Itabashi M, Hashiguchi Y, Kotera Y, Kobayashi S, Yamaguchi T, Morita S, Miyazaki M, Sugihara K; Joint Committee for Nationwide Survey on Colorectal Liver Metastasis. Sakamoto K, et al. Among authors: morita s. J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):115-123. doi: 10.1002/jhbp.510. Epub 2017 Dec 5. J Hepatobiliary Pancreat Sci. 2018. PMID: 28990311
Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial.
Kaido T, Shinoda M, Inomata Y, Yagi T, Akamatsu N, Takada Y, Ohdan H, Shimamura T, Ogura Y, Eguchi S, Eguchi H, Ogata S, Yoshizumi T, Ikegami T, Yamamoto M, Morita S, Uemoto S. Kaido T, et al. Among authors: morita s. Nutrition. 2018 Oct;54:68-75. doi: 10.1016/j.nut.2018.02.022. Epub 2018 Mar 20. Nutrition. 2018. PMID: 29747091 Clinical Trial.
A Prospective, Randomized Phase II Study of Adjuvant Gemcitabine Versus S-1 After Major Hepatectomy for Biliary Tract Cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group.
Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T; Kansai Hepato-Biliary Oncology (KHBO) Group. Kobayashi S, et al. Among authors: morita s. Ann Surg. 2019 Aug;270(2):230-237. doi: 10.1097/SLA.0000000000002865. Ann Surg. 2019. PMID: 30339627 Clinical Trial.
3,484 results